ANTHERA PHARMACEUTICALS$1.85
-0.06
| Last Trade: |
1.85 |
| Trade Time: |
May 25 10:55 AM Eastern Daylight Time |
| Change: |
-0.06 (-3.14 %) |
| Prev Close: |
1.91 |
| Open: |
1.92 |
| Bid: |
1.85 |
| Ask: |
1.87 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : -79% - ANTH has underperformed the S&P 500 by 79%
Get Trend Analysis
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
3/22/2012
|
ORBIMED ADVISORS LLC
|
Director
|
-1,306,700
|
$2.40
|
-50.45%
|
|
3/21/2012
|
ORBIMED ADVISORS LLC
|
Director
|
-125,000
|
$2.87
|
-4.60%
|
|
3/20/2012
|
ORBIMED ADVISORS LLC
|
Director
|
-116,800
|
$2.90
|
-4.12%
|
|
3/1/2012
|
ODINK DEBRA
|
Chief Technology Officer
|
-2,000
|
$6.57
|
-6.98%
|
|
2/23/2012
|
Hislop Colin
|
Chief Medical Officer
|
40,000
|
$0.26
|
101.22%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ANTH), click here.
Free Reports
|
|
